Evidence map›Paper›PMID 34342526›Full record

ArticleJournal of cardiovascular pharmacology and therapeutics2021

Remote Ischemic Perconditioning Ameliorates Myocardial Ischemia and Reperfusion-Induced Coronary Endothelial Dysfunction and Aortic Stiffness in Rats.

Petra Lujza Szabó, Christopher Dostal, Patrick Michael Pilz, Ouafa Hamza, Eylem Acar, Simon Watzinger, Shalett Mathew, Gerd Kager, Seth Hallström, Bruno K Podesser and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cardiovascular pharmacology and therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Petra Lujza SzabóLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5465-8391
Christopher DostalLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-4961-6458
Patrick Michael PilzLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6149-8736
Ouafa HamzaLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.
Eylem AcarLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.
Simon WatzingerLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.
Shalett MathewLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.
Gerd KagerDivision of Physiological Chemistry, Otto Loewi Research Center, 31475Medical University Graz, Graz, Austria.
Seth HallströmDivision of Physiological Chemistry, Otto Loewi Research Center, 31475Medical University Graz, Graz, Austria.
Bruno K PodesserLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4641-7202
Attila KissLudwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research, 27271Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATMedical University of Graz · ATCardiovascular Institute of the South · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVascular stiffness and endothelial dysfunction are accelerated by acute myocardial infarction (AMI) and subsequently increase the risk for recurrent coronary events.

aimTo explore whether remote ischemic perconditioning (RIPerc) protects against coronary and aorta endothelial dysfunction as well as aortic stiffness following AMI.

methodsMale OFA-1 rats were subjected to 30 min of occlusion of the left anterior descending artery (LAD) followed by reperfusion either 3 or 28 days with or without RIPerc. Three groups: (1) sham operated (Sham, without LAD occlusion); (2) myocardial ischemia and reperfusion (MIR) and (3) MIR + RIPerc group with 3 cycles of 5 minutes of IR on hindlimb performed during myocardial ischemia were used. Assessment of vascular reactivity in isolated septal coronary arteries (non-occluded) and aortic rings as well as aortic stiffness was assessed by wire myography either 3 or 28 days after AMI, respectively. Markers of pro-inflammatory cytokines, adhesion molecules were assessed by RT-qPCR and ELISA.

resultsMIR promotes impaired endothelial-dependent relaxation in septal coronary artery segments, increased aortic stiffness and adverse left ventricular remodeling. These changes were markedly attenuated in rats treated with RIPerc and associated with a significant decline in P-selectin, IL-6 and TNF-α expression either in infarcted or non-infarcted myocardial tissue samples.

conclusionsOur study for the first time demonstrated that RIPerc alleviates MIR-induced coronary artery endothelial dysfunction in non-occluded artery segments and attenuates aortic stiffness in rats. The vascular protective effects of RIPerc are associated with ameliorated inflammation and might therefore be caused by reduced inflammatory signaling.

Indexed as

Vascular StiffnessAnimalsCoronary VesselsCytokinesInflammationIschemic Preconditioning, MyocardialMaleMyocardial InfarctionMyocardial IschemiaMyocardial ReperfusionMyocardial Reperfusion InjuryRatsCytokinesacute myocardial infarctionendotheliumheart diseaseischemia-reperfusion injury

Identifiers

PMID34342526
PMCPMC8547239
OpenAlexW3191520033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.